We are monitoring the impact of COVID-19 on APAC Apheresis Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2961
Share on
Share on

Asia Pacific Apheresis Market Research Report - Segmented By Product, Procedure, Application, Technology, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2961
Pages: 155

APAC Apheresis Market Size (2021 to 2026)

The size of the Asia Pacific Apheresis Market was worth USD 0.33 billion in 2021 and estimated to be growing at a CAGR of 12.58%, to reach USD 0.59 billion by 2026.

Apheresis is a medical procedure that involves the purifying of blood or the separation of distinct blood components. Separation of the component was accomplished using two methods like centrifugation and filtration. The presence of modern blood collection facilities, a strong presence of blood collection centers, significant product penetration, and high awareness among persons regarding blood component donation are all factors that contribute to Asia Pacific's success. In addition, the Asia Pacific area market is being driven by a growing end-user base, a growing population, and an increase in the prevalence of blood disorders.

The rising prevalence of chronic diseases and the increasing number of trauma and injury cases, the growing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns about blood safety, the rise in the number of complex surgical procedures, and favorable reimbursement for apheresis procedures are primarily accelerating the apheresis market growth in the APAC region.

In addition, the development of innovative apheresis techniques and the rising prevalence of various chronic diseases, blood-related diseases, and other diseases are driving the apheresis market. Increased demand for various blood components, increasing complexity of surgical operations, and an increase in the number of accidents across the Asia Pacific are expected to contribute to the market's rise during the forecast period. Private blood collection centers, which recruit donors through paid plans, combat a lack of regular blood donors. In recent years, hospitals have increased their use of apheresis equipment to collect and store essential blood components, reducing their reliance on private blood suppliers and collection centers.

The increase of platelet donors and biopharmaceutical companies R&D investments are expected to have a significant influence. In addition, the rising prevalence of blood-related illnesses is expected to drive up demand for apheresis devices and kits. Furthermore, favorable government measures and a recovery framework are expected to boost demand over the forecast period.

According to the National Health Service (NHS) Blood and Transplant, the need for platelets is increasing. While a shortage of qualified professionals and the ease with which blood and blood products can be infected, the risk of infection also contributes to the market's slow growth. However, the expensive cost of apheresis devices and therapeutic apheresis procedures, as well as the rental model's installation of apheresis machines, may limit market expansion. In addition, fewer blood donations using apheresis due to a lack of awareness and strict donor recruitment criteria are factors that are likely to stifle market growth and limit it to some extent in the coming years.

This research report on the Asia-pacific apheresis market has been segmented and sub-segmented into the following categories:

By Product: 

  • Devices
  • Disposables

By Procedure: 

  • Donor
  • Therapeutic
  • Photopheresis

By Application: 

  • Renal Diseases
  • Neurology
  • Cancer
  • Hematology
  • Autoimmune Diseases
  • Cardiovascular Diseases

By Technology: 

  • Centrifuge
  • Membrane Separation

By End User: 

  • Private Blood Collection Centres
  • Public Blood Collection Centres
  • Hospitals

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia Pacific is one of the most lucrative markets for the growth of the Apheresis market and is projected to grow the highest during the forecast period. Factors such as the growing prevalence of blood disorders requiring plasma and platelet transfusion, increasing demographics, and emerging economies in countries such as India and China are anticipated to lead to the growth of this region's market.  

Furthermore, favorable reimbursement regulations and improved healthcare infrastructure are propelling apheresis equipment sales in India, China, and Japan. In addition, other factors, such as the introduction of advanced variations with automated interface systems, screen navigation, and graphical user interface displays, and increased research and development spending, are projected to boost the market in the future years.

KEY MARKET PLAYERS:

A few of the notable companies playing a leading role in the Asia-pacific apheresis market profiled in the report are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.

1. Introduction       

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Product                        

      5.1.1 Introduction           

      5.1.2 Apheresis devices

                      5.1.2.1 Plasma separators

                      5.1.2.2 Plasma component separators

                      5.1.2.3 Immunoadsorption Columns

                      5.1.2.4 Plasma Perfusion Columns

                      5.1.2.5 Hemoperfusion Columns

      5.1.3 Apheresis disposables       

      5.1.4  Y-o-Y Growth Analysis, By Product              

      5.1.5  Market Attractiveness Analysis, By Product            

      5.1.6  Market Share Analysis, By Product              

                5.2 Procedure                   

      5.2.1 Introduction           

      5.2.2 Donor Apheresis  

      5.2.3 Therapeutic Apheresis       

      5.2.4 Y-o-Y Growth Analysis, By Procedure          

      5.2.5 Market Attractiveness Analysis, By Procedure        

      5.2.6 Market Share Analysis, By Procedure          

                5.3 Application                 

      5.3.1 Introduction           

      5.3.2 Renal Diseases      

      5.3.3 Neurology               

      5.3.4 Cancer      

      5.3.5 Hematology            

      5.3.6 Autoimmune Diseases       

      5.3.7 Cardiovascular Diseases    

      5.3.8 Y-o-Y Growth Analysis, By Application         

      5.3.9 Market Attractiveness Analysis, By Application       

      5.3.10 Market Share Analysis, By Application      

                5.4 Technology                 

      5.4.1 Centrifugation       

                      5.4.1.1 Intermittent Flow

                      5.4.1.2 Continuous Flow

      5.4.2 Membrane Separation      

      5.4.3 Y-o-Y Growth Analysis, By Technology        

      5.4.4  Market Attractiveness Analysis, By Technology     

      5.4.5  Market Share Analysis, By Technology       

                5.5 End user                      

      5.5.1 Introduction           

      5.5.2 Private Blood Collection Centres   

      5.5.3 Public Blood Collection Centres      

      5.5.4 Hospitals  

      5.4.5 Y-o-Y Growth Analysis, By End user              

      5.4.6  Market Attractiveness Analysis, By End user           

      5.4.7  Market Share Analysis, By End user            

6. Geographical Analysis                    

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Product

                      6.1.3.3 By Procedure

                      6.1.3.4 By Application

                      6.1.3.5 By Technology

                      6.1.3.6 By End user

      6.1.4  Market Attractiveness Analysis     

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Product

                      6.1.4.3 By Procedure

                      6.1.4.4 By Application

                      6.1.4.5 By Technology

                      6.1.4.6 By End user

      6.1.5  Market Share Analysis      

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Product

                      6.1.5.3 By Procedure

                      6.1.5.4 By Application

                      6.1.5.5 By Itechnology

                      6.1.5.6 By End user

                6.2 China   

                6.3 India    

                6.4 Japan  

                6.5 South Korea     

                6.6 Australia                      

7. Strategic Analysis             

                7.1 PESTLE analysis                         

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis              

                8.1 Asahi Kasei Medical Co., Ltd.     

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 Haemonetics Corporation                    

                8.3 Terumo BCT, Inc.                      

                8.4 Fresenius Medical Care                         

                8.5 Kawasumi Laboratories Inc.                 

                8.6 Cerus Corporation                   

                8.7 Hemacare Corporation

                8.8 Kaneka Corporation                

                8.9 Braun Melsungen AG   

                8.10 Nikkiso Co., Ltd.                     

                8.11 Therakos, Inc.,                        

                8.12 Medica S.p.A.

9. Competitive Landscape                 

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                 

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Apheresis Market, By Product, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Devices Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Disposables Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Apheresis Market, By Procedure, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Donor Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Therapeutic Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Apheresis Market, By Application, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Renal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia Pacific Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia Pacific Autoimmune Diseases  Market, By Region, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia Pacific Apheresis Market, By Technology, From 2021 to 2026 (USD Billion)
  15. Asia Pacific Centrifuge separation Market, By Region, From 2021 to 2026 (USD Billion)
  16. Asia Pacific Membrane Separation Market, By Region, From 2021 to 2026 (USD Billion)
  17. Asia Pacific Apheresis Market, By End user, From 2021 to 2026 (USD Billion)
  18. Asia Pacific Private Blood Collection Centres Market, By Region, From 2021 to 2026 (USD Billion)
  19. Asia Pacific Public Blood Collection Centres Market, By Region, From 2021 to 2026 (USD Billion)
  20. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  21. Japan Apheresis Market, By Product, From 2021 to 2026 (USD Billion)
  22. Japan Apheresis Market, By Procedure, From 2021 to 2026 (USD Billion)
  23. Japan Apheresis Market, By Application, From 2021 to 2026 (USD Billion)
  24. Japan Apheresis Market, By Technology, From 2021 to 2026 (USD Billion)
  25. Japan Apheresis Market, By End user, From 2021 to 2026 (USD Billion)
  26. China Apheresis Market, By Product, From 2021 to 2026 (USD Billion)
  27. China Apheresis Market, By Procedure, From 2021 to 2026 (USD Billion)
  28. China Apheresis Market, By Application, From 2021 to 2026 (USD Billion)
  29. China Apheresis Market, By Technology, From 2021 to 2026 (USD Billion)
  30. China Apheresis Market, By End user, From 2021 to 2026 (USD Billion)
  31. India Apheresis Market, By Product, From 2021 to 2026 (USD Billion)
  32. India Apheresis Market, By Procedure, From 2021 to 2026 (USD Billion)
  33. India Apheresis Market, By Application, From 2021 to 2026 (USD Billion)
  34. India Apheresis Market, By Technology, From 2021 to 2026 (USD Billion)
  35. India Apheresis Market, By End user, From 2021 to 2026 (USD Billion)
  36. Australia Apheresis Market, By Product, From 2021 to 2026 (USD Billion)
  37. Australia Apheresis Market, By Procedure, From 2021 to 2026 (USD Billion)
  38. Australia Apheresis Market, By Application, From 2021 to 2026 (USD Billion)
  39. Australia Apheresis Market, By Technology, From 2021 to 2026 (USD Billion)
  40. Australia Apheresis Market, By End user, From 2021 to 2026 (USD Billion)
  41. South Korea Apheresis Market, By Product, From 2021 to 2026 (USD Billion)
  42. South Korea Apheresis Market, By Procedure, From 2021 to 2026 (USD Billion)
  43. South Korea Apheresis Market, By Application, From 2021 to 2026 (USD Billion)
  44. South Korea Apheresis Market, By Technology, From 2021 to 2026 (USD Billion)
  45. South Korea Apheresis Market, By End-user, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample